TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Novo Nordisk Pharma Operations A/S
Closing information (x1000 EUR)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover |
13,263
|
10,646
|
10,849 |
Earnings before taxes |
591
|
502
|
518 |
Total assets |
9,529
|
7,350
|
7,486 |
Current assets |
8,047
|
6,523
|
5,922 |
Current liabilities |
5,714
|
4,947
|
5,120 |
Equity capital |
2,762
|
2,337
|
1,924 |
- share capital |
67
![]() |
67
![]() |
67 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency |
29.0%
|
31.8%
|
25.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
4.5%
|
4.7%
|
4.8% |
Return on assets (ROA) | |||
Current ratio |
140.8%
|
131.9%
|
115.7% |
Return on equity (ROE) |
21.4%
|
21.5%
|
26.9% |
Change turnover |
2,613
|
-248
|
2,635 |
Change turnover % |
25%
|
-2%
|
32% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.